Compound E, gamma;-secretase inhibitor
Be the first to review this product! Submit a review
|
(11 Publications)
Cell-permeable, selective, non-competitive, potent γ-secretase inhibitor (IC50 = 0.3 nM). MW 490.5.
- Active in vitro and in vivo
- Available in different sizes to fit your experimental needs
View Alternative Names
6530402N02Rik, AD3, AD3L, AD3LP, AD4, AD5, AL138795.3, APH1A gamma secretase subunit, APH1A_HUMAN, APH1B_HUMAN, Ad3h, Alzheimer disease 4, Anterior Pharynx Defective 1, Anterior pharynx defective 1 homolog A, Anterior pharynx defective 1 homolog B, Anterior pharynx defective 1 homolog B (C. elegans), Anterior pharynx defective 1B like, Anterior pharynx defective 1b short splicing variant, Aph-1alpha, Aph-1beta, CGI 78, CMD1V, DKFZp564D0372, E5-1, FAD, Gamma Secretase Subunit PEN2, Gamma secretase sununit, Gamma-secretase subunit APH-1A, Gamma-secretase subunit Aph-1b, Gamma-secretase subunit PEN-2, Hematopoietic stem/progenitor cells protein MDS033, Homo Sapiens Clone CC44 Senilin 1, Likely ortholog of C. elegans anterior pharynx defective 1A, MDS033, MSTP064, OTTHUMP00000035671, OTTHUMP00000035672, OTTHUMP00000228286, OTTHUMP00000228288, PEN2_HUMAN, PRO 1328, PS-1, PS-2, PS1-CTF12, PSEN1, PSEN2, PSF, PSFL, PSN1_HUMAN, PSN2_HUMAN, PSNL1, PSNL2, Presenilin 2, Presenilin 2 (Alzheimer disease 4), Presenilin Enhancer 2, Presenilin enhancer 2 homolog, Presenilin enhancer protein 2, Presenilin stabilisation factor like, Presenilin-1 CTF12, Presenilin-2 CTF subunit, Presenilin-stabilization factor, Presenilin-stabilization factor-like, Protein S182, S182, STM-2, TAAV 688, UNQ579/PRO1141, psenen
- Chemical Structure
Lab
Chemical Structure - Compound E, gamma;-secretase inhibitor (AB142164)
2D chemical structure image of ab142164, Compound E, gamma;-secretase inhibitor
- FuncS
Collaborator6479473****
Functional Studies - Compound E, gamma;-secretase inhibitor (AB142164)
Kc167 cells were treated with varying concentrations of compound E (ab142164) in DMSO for 16hr at 25°C; DMSO only was used as the negative control. The cells were further incubated for 30 minutes with 4mM EGTA in PBS (in the presence of compound E), and were then lysed for analysis. To measure Notch activity, Notch targets E(spl)mβ-HLH and E(spl)m3-HLH mRNA levels were assayed. Data shows the fold change of mRNA levels of E(spl)mβ-HLH and E(spl)m3-HLH under different conditions, normalised to DMSO treatment (negative control). Notch activation by EGTA is abrogated by treatment with compound E.
This image is courtesy of an Abreview submitted by a verified customer
Product details
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Pathways
PS-1 and PS-2 are central to the Notch signaling pathway and amyloid precursor protein processing. Within these pathways gamma-secretase plays an essential role in cleaving substrates which allows for proper signaling and cellular communication. Here APP and Notch are critical substrates processed by this proteolytic activity. Other related proteins include the ligands for Notch signaling which presenilins help process through their enzymatic function in the gamma-secretase complex.
Biological function summary
Presenilins are important for the intramembrane proteolysis of various type 1 transmembrane proteins. They function as part of the gamma-secretase complex to facilitate the cleavage of amyloid precursor protein (APP) which is an essential process for generating amyloid-beta peptides. These peptides can aggregate and form plaques linked to neurodegeneration. The gamma-secretase complex includes other important proteins like PEN2 Aph1a and Aph1b which together with presenilins execute the proteolytic process.
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:460 PubMed39779681
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:21912 PubMed39300145
2024
Applications
Unspecified application
Species
Unspecified reactive species
Brain communications 6:fcae244 PubMed39144751
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature cell biology 26:353-365 PubMed38443567
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular neuroscience 16:866020 PubMed35685988
2022
Applications
Unspecified application
Species
Unspecified reactive species
eLife 11: PubMed35438077
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of visualized experiments : JoVE : PubMed34515684
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 25:2563-2576.e9 PubMed30485820
2018
Applications
Unspecified application
Species
Unspecified reactive species
eLife 7: PubMed30394875
2018
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 16:4623-4631 PubMed30542413
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com